BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 29654162)

  • 1. NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis.
    Yang M; Qiu Y; Jin Y; Liu W; Wang Q; Yi H; Tang S
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00696. PubMed ID: 33300686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shared heritability and functional enrichment across six solid cancers.
    Jiang X; Finucane HK; Schumacher FR; Schmit SL; Tyrer JP; Han Y; Michailidou K; Lesseur C; Kuchenbaecker KB; Dennis J; Conti DV; Casey G; Gaudet MM; Huyghe JR; Albanes D; Aldrich MC; Andrew AS; Andrulis IL; Anton-Culver H; Antoniou AC; Antonenkova NN; Arnold SM; Aronson KJ; Arun BK; Bandera EV; Barkardottir RB; Barnes DR; Batra J; Beckmann MW; Benitez J; Benlloch S; Berchuck A; Berndt SI; Bickeböller H; Bien SA; Blomqvist C; Boccia S; Bogdanova NV; Bojesen SE; Bolla MK; Brauch H; Brenner H; Brenton JD; Brook MN; Brunet J; Brunnström H; Buchanan DD; Burwinkel B; Butzow R; Cadoni G; Caldés T; Caligo MA; Campbell I; Campbell PT; Cancel-Tassin G; Cannon-Albright L; Campa D; Caporaso N; Carvalho AL; Chan AT; Chang-Claude J; Chanock SJ; Chen C; Christiani DC; Claes KBM; Claessens F; Clements J; Collée JM; Correa MC; Couch FJ; Cox A; Cunningham JM; Cybulski C; Czene K; Daly MB; deFazio A; Devilee P; Diez O; Gago-Dominguez M; Donovan JL; Dörk T; Duell EJ; Dunning AM; Dwek M; Eccles DM; Edlund CK; Edwards DRV; Ellberg C; Evans DG; Fasching PA; Ferris RL; Liloglou T; Figueiredo JC; Fletcher O; Fortner RT; Fostira F; Franceschi S; Friedman E; Gallinger SJ; Ganz PA; Garber J; García-Sáenz JA; Gayther SA; Giles GG; Godwin AK; Goldberg MS; Goldgar DE; Goode EL; Goodman MT; Goodman G; Grankvist K; Greene MH; Gronberg H; Gronwald J; Guénel P; Håkansson N; Hall P; Hamann U; Hamdy FC; Hamilton RJ; Hampe J; Haugen A; Heitz F; Herrero R; Hillemanns P; Hoffmeister M; Høgdall E; Hong YC; Hopper JL; Houlston R; Hulick PJ; Hunter DJ; Huntsman DG; Idos G; Imyanitov EN; Ingles SA; Isaacs C; Jakubowska A; James P; Jenkins MA; Johansson M; Johansson M; John EM; Joshi AD; Kaneva R; Karlan BY; Kelemen LE; Kühl T; Khaw KT; Khusnutdinova E; Kibel AS; Kiemeney LA; Kim J; Kjaer SK; Knight JA; Kogevinas M; Kote-Jarai Z; Koutros S; Kristensen VN; Kupryjanczyk J; Lacko M; Lam S; Lambrechts D; Landi MT; Lazarus P; Le ND; Lee E; Lejbkowicz F; Lenz HJ; Leslie G; Lessel D; Lester J; Levine DA; Li L; Li CI; Lindblom A; Lindor NM; Liu G; Loupakis F; Lubiński J; Maehle L; Maier C; Mannermaa A; Marchand LL; Margolin S; May T; McGuffog L; Meindl A; Middha P; Miller A; Milne RL; MacInnis RJ; Modugno F; Montagna M; Moreno V; Moysich KB; Mucci L; Muir K; Mulligan AM; Nathanson KL; Neal DE; Ness AR; Neuhausen SL; Nevanlinna H; Newcomb PA; Newcomb LF; Nielsen FC; Nikitina-Zake L; Nordestgaard BG; Nussbaum RL; Offit K; Olah E; Olama AAA; Olopade OI; Olshan AF; Olsson H; Osorio A; Pandha H; Park JY; Pashayan N; Parsons MT; Pejovic T; Penney KL; Peters WHM; Phelan CM; Phipps AI; Plaseska-Karanfilska D; Pring M; Prokofyeva D; Radice P; Stefansson K; Ramus SJ; Raskin L; Rennert G; Rennert HS; van Rensburg EJ; Riggan MJ; Risch HA; Risch A; Roobol MJ; Rosenstein BS; Rossing MA; De Ruyck K; Saloustros E; Sandler DP; Sawyer EJ; Schabath MB; Schleutker J; Schmidt MK; Setiawan VW; Shen H; Siegel EM; Sieh W; Singer CF; Slattery ML; Sorensen KD; Southey MC; Spurdle AB; Stanford JL; Stevens VL; Stintzing S; Stone J; Sundfeldt K; Sutphen R; Swerdlow AJ; Tajara EH; Tangen CM; Tardon A; Taylor JA; Teare MD; Teixeira MR; Terry MB; Terry KL; Thibodeau SN; Thomassen M; Bjørge L; Tischkowitz M; Toland AE; Torres D; Townsend PA; Travis RC; Tung N; Tworoger SS; Ulrich CM; Usmani N; Vachon CM; Van Nieuwenhuysen E; Vega A; Aguado-Barrera ME; Wang Q; Webb PM; Weinberg CR; Weinstein S; Weissler MC; Weitzel JN; West CML; White E; Whittemore AS; Wichmann HE; Wiklund F; Winqvist R; Wolk A; Woll P; Woods M; Wu AH; Wu X; Yannoukakos D; Zheng W; Zienolddiny S; Ziogas A; Zorn KK; Lane JM; Saxena R; Thomas D; Hung RJ; Diergaarde B; McKay J; Peters U; Hsu L; García-Closas M; Eeles RA; Chenevix-Trench G; Brennan PJ; Haiman CA; Simard J; Easton DF; Gruber SB; Pharoah PDP; Price AL; Pasaniuc B; Amos CI; Kraft P; Lindström S
    Nat Commun; 2019 Jan; 10(1):431. PubMed ID: 30683880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PXR: a center of transcriptional regulation in cancer.
    Xing Y; Yan J; Niu Y
    Acta Pharm Sin B; 2020 Feb; 10(2):197-206. PubMed ID: 32082968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis.
    Yang H; Ren L; Wang Y; Bi X; Li X; Wen M; Zhang Q; Yang Y; Jia Y; Li Y; Zang A; Wei Y; Dai G
    Cell Death Dis; 2020 Oct; 11(10):851. PubMed ID: 33051436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PXR-ABC drug transporters/CYP-mediated ursolic acid transport and metabolism in vitro and vivo.
    Jinhua W; Ying Z; Yuhua L
    Arch Pharm (Weinheim); 2020 Sep; 353(9):e2000082. PubMed ID: 32628284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β induced chemoresistance in liver cancer is modulated by xenobiotic nuclear receptor PXR.
    Bhagyaraj E; Ahuja N; Kumar S; Tiwari D; Gupta S; Nanduri R; Gupta P
    Cell Cycle; 2019 Dec; 18(24):3589-3602. PubMed ID: 31739702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress.
    Sári Z; Mikó E; Kovács T; Jankó L; Csonka T; Lente G; Sebő É; Tóth J; Tóth D; Árkosy P; Boratkó A; Ujlaki G; Török M; Kovács I; Szabó J; Kiss B; Méhes G; Goedert JJ; Bai P
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32854297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyroptosis: mechanisms and diseases.
    Yu P; Zhang X; Liu N; Tang L; Peng C; Chen X
    Signal Transduct Target Ther; 2021 Mar; 6(1):128. PubMed ID: 33776057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations between Pregnane X Receptor and Breast Cancer Growth and Progression.
    Creamer BA; Sloan SNB; Dennis JF; Rogers R; Spencer S; McCuen A; Persaud P; Staudinger JL
    Cells; 2020 Oct; 9(10):. PubMed ID: 33076284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation Modulates the Coregulatory Protein Exchange of the Nuclear Receptor Pregnane X Receptor.
    Cui W; Shen X; Agbas E; Tompkins B; Cameron-Carter H; Staudinger JL
    J Pharmacol Exp Ther; 2020 Jun; 373(3):370-380. PubMed ID: 32205367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between peroxisome proliferator-activated receptor γ-2 gene Pro12Ala polymorphisms and risk of hypertension: an updated meta-analysis.
    Zhang M; Zhang J; Li L; Wang Q; Feng L
    Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30777927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnane X Receptor Polymorphisms and Risk of Inflammatory Bowel Disease: A Meta-Analysis.
    Guo X; Yan M
    Immunol Invest; 2017 Aug; 46(6):566-576. PubMed ID: 28742404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnane X receptor (PXR/NR1I2) gene haplotypes modulate susceptibility to inflammatory bowel disease.
    Glas J; Seiderer J; Fischer D; Tengler B; Pfennig S; Wetzke M; Beigel F; Olszak T; Weidinger M; Göke B; Ochsenkühn T; Folwaczny M; Müller-Myhsok B; Diegelmann J; Czamara D; Brand S
    Inflamm Bowel Dis; 2011 Sep; 17(9):1917-24. PubMed ID: 21830270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms in PXR and NF-κB1 influence susceptibility to anti-tuberculosis drug-induced liver injury.
    Zhang J; Zhao Z; Bai H; Wang M; Jiao L; Peng W; Wu T; Liu T; Chen H; Song X; Wu L; Hu X; Wu Q; Zhou J; Song J; Lyv M; Ying B
    PLoS One; 2019; 14(9):e0222033. PubMed ID: 31490979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive assessment and meta-analysis of the association between CTNNB1 polymorphisms and cancer risk.
    Li Y; Zhang F; Yang D
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28963373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESR1 Gene Polymorphisms and Prostate Cancer Risk: A HuGE Review and Meta-Analysis.
    Wang YM; Liu ZW; Guo JB; Wang XF; Zhao XX; Zheng X
    PLoS One; 2013; 8(6):e66999. PubMed ID: 23805288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between
    Wen J; Lv Z; Ding H; Fang X; Sun M
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654162
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.